Relationship between insulin resistance and accumulation of coronary risk factors

Diabetes, Obesity and Metabolism

Volumn 4, Issue 6, 2002, Pages 388-393

  Ohnishi, H ^a,b   Saitoh, S ^a   Ura, N ^a   Takagi, S ^a   Obara, F ^a   Akasaka, H ^a   Oimatsu, H ^a   Shimamoto, K ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

75 g glucose tolerance test; Community based survey; Coronary risk factors; HOMA R; Insulin resistance

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CORONARY RISK; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; FEMALE; FREQUENCY ANALYSIS; GLUCOSE CLAMP TECHNIQUE; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; JAPAN; LOADING TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OBESITY; RISK FACTOR; RURAL POPULATION; STATISTICAL DISTRIBUTION; SYSTOLIC BLOOD PRESSURE;

EID: 0036847662     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2002.00232.x     Document Type: Article

References (23)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
2. DeFronzo RA. The glucose clamp technique: a method for quanifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E233.
3. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
4. Oimatsu H, Saitoh S, Ura N, Shimamoto K. A practical index for evaluation of insulin resistance. J Japan Diabetes Soc 2000; 43: 205-213 (in Japanese).
5. Joint National Committees on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
6. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
7. Matsuzawa Y. The new diagnostic criteria of obesity. J Japan Soc for Study Obesity 2000; 6: 18-28 (in Japanese).
8. Investigating Committee of Guideline for Diagnosis and Treatment of Hyperlipidemias, Japan Atherosclerosis Society. Guideline for Diagnosis and Treatment of Hyperlipidemias in Adults. J Japan Atherosclerosis Soc 1997; 25: 1-34 (in Japanese).
9. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
10. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
11. Despres JP, Lamarche B, Mauriege P et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334: 952-957.
12. Ariza CR, Frati AC, Gomez G, Almazan A. Hyperinsulinemia in patients with coronary heart disease in absence of over risk factors. Arch Med Res 1997; 28: 115-119.
13. Orchard TJ, Lloyd CE, Wing RR. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann Epidemiol 1994; 4: 40-45.
14. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 1995; 91: 831-837.
15. Harano Y, Ohgaku S, Hidaka H et al. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endoclinol Metab 1977; 45: 1124-1127.
16. Bergman RN. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 1989; 38: 1512-1527.
17. Yamada N, Yoshinaga H, Sakurai N et al. Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance. Diabetes Care 1994; 17: 107-114.
18. Ruige BJ, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease. A Meta-Anal Circulation 1998; 97: 996-1001.
19. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The northern Sweden MONICA population study. J Intern Med 1993; 234: 263-270.
20. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
21. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. Insulin resistance syndrome predicts coronary heart disease events in elderly non-diabetic men. Circulation 1999; 100: 123-128.
22. Iwamoto Y. The clinical usefulness of HOMA-R. Diabetes J 1998; 26: 25-27 (in Japanese).
23. Hosojima H. Establishment of a practical index indicating insulin resistance in impaired glucose tolerance with obesity. J Jap Diabetes Soc 1998; 41: 433-441 (in Japanese).